TITAN PHARMACEUTICALS INC 4
4 · TITAN PHARMACEUTICALS INC · Filed Dec 16, 2015
Insider Transaction Report
Form 4
TITAN PHARMACEUTICALS INCTTNP.OB
BHONSLE SUNIL
DirectorPresident
Transactions
- Award
Option to Purchase Common Stock
2015-12-14+180,000→ 180,000 totalExercise: $5.10Exp: 2025-12-14→ Common Stock (180,000 underlying)
Footnotes (1)
- [F1]The options vest in 24 equal monthly installments commencing on the grant date.